CAC2 actively supports and promotes current research and treatment initiatives aimed at improving outcomes for children with cancer. Explore the list of ongoing projects below.
Current Active Projects:
Ethics Think Tank
The Ethics Think Tank team employs the scientific method to identify and explore the ethics of research funding within a landscape that includes academics, industry, regulatory, and patients. This group’s first project has been presented at an international conference and published. The team is constantly evolving and during the next phase called the Patient Advocate Industry Relationships (PAIR) Project, the team will draw on extant resources and developing new resources to assist non-profit organizations as they strive to support pediatric cancer drug development ethically.
Foundation Match for Joint Research Funding
Supported by Focused Ultrasound Foundation.
The foundation match for joint research funding team has built a searchable web platform for CAC2 member organizations with like-minded missions to connect, collaborate, and fund research and other projects with a goal of preventing duplication of effort and creating a more coordinated funding effort to support research.
International Cancer Research Partnership Database
In 2015, CAC2 joined forces with the International Cancer Research Partnership database (ICRPartnership.org). Since then, almost half of CAC2 research members have contributed their funded projects to be listed and cataloged in the ICRP database.
“Talent wins games, but teamwork and intelligence win championships.” – Michael Jordan
The Research and Treatment Interest Group strives to establish CAC2 as a credible resource for moving the field of pediatric cancer forward through thoughtful, progressive studies and projects.
Assorted News from the Last Week: The Global Initiative for Childhood Cancer aims for a two-thirds remission rate by 2030, saving the lives of approximately
In CAC2’s June webinar, “Beyond the Signature: Demystifying Informed Consent in Childhood Cancer,” we brought together an extraordinary panel of experts, including a clinical ethicist,